Search - tctmd.com

Displaying 701 - 720 of 7390

Sort: Relevancy | Date

$TCT 808: Please mind the gap: A case of recurrent stent fracture$

Presentation TCT 2023

TCT 808: Please mind the gap: A case of recurrent stent fracture

Presenter: Preethi Suresh

October 25, 2023

Presentation TCT 2023

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

Presenter: Taehoon Kim

October 25, 2023

Presentation TCT 2023

Provisional LMCA Stenting Is My Default

Presenter: Goran Stankovic

October 25, 2023

Presentation TCT 2023

TCT 798: Acute Stent Underexpansion in Saphenous Vein Grafts Bailed Out with Intravascular Lithotripsy

Presenter: Sumon Roy

October 25, 2023

Presentation TCT 2023

TCT 807: Navigating the Unexpected: Stent Fracture Following Intravascular Lithotripsy in PCI-RIMA Graft: Lessons Learned.

Presenter: Gemina Doolub

October 25, 2023

Presentation TCT 2023

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

Presenter: Azfar Zaman

October 25, 2023

Presentation TCT 2023

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Presenter: Hyunki LEE

October 25, 2023

Presentation TCT 2023

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

Presenter: Usman Naseer

October 25, 2023

Presentation TCT 2023

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

Presenter: Doosup Shin

October 25, 2023

Presentation TCT 2023

TCT 220: Stent Elongation in-Vivo is Mediated by Lesion Morphology as Defined by OCT.

Presenter: Michael McGarvey

October 25, 2023

Presentation TCT 2023

TCT 956: ´´Only Steel can Heal´´ Retrograde stenting of the left main after double chimney stenting in TAVR-in-TAVR-in-SAVR

Presenter: Kambis Mashayekhi

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

Presentation TCT 2023

What to Do When Iliocaval Stents Fail

Presenter: Pallav Kolli

October 25, 2023

Presentation TCT 2023

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Presenter: Juan Iglesias

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

TCT 514: Safety and Efficacy of 19 different Stent Strategies in Percutaneous Coronary Intervention. A Trial-Sequential, Influential, Bivariate and Network Meta-Analysis

Presenter: Harigopal Sandhyavenu

October 25, 2023

Presentation TCT 2023

TCT 466: Unintended deformation of stents during bifurcation PCI. An OCTOBER trial substudy

Presenter: Lene Andreasen

October 25, 2023

Presentation TCT 2023

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Presenter: Giovanni Esposito

October 25, 2023

Advertisement

TCT 808: Please mind the gap: A case of recurrent stent fracture

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

Provisional LMCA Stenting Is My Default

TCT 798: Acute Stent Underexpansion in Saphenous Vein Grafts Bailed Out with Intravascular Lithotripsy

TCT 807: Navigating the Unexpected: Stent Fracture Following Intravascular Lithotripsy in PCI-RIMA Graft: Lessons Learned.

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

TCT 220: Stent Elongation in-Vivo is Mediated by Lesion Morphology as Defined by OCT.

TCT 956: ´´Only Steel can Heal´´ Retrograde stenting of the left main after double chimney stenting in TAVR-in-TAVR-in-SAVR

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

What to Do When Iliocaval Stents Fail

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

TCT 514: Safety and Efficacy of 19 different Stent Strategies in Percutaneous Coronary Intervention. A Trial-Sequential, Influential, Bivariate and Network Meta-Analysis

TCT 466: Unintended deformation of stents during bifurcation PCI. An OCTOBER trial substudy

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content